(AKBA) |
| 0 (0%) 07-28 00:03 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.71 |
| Resistance 1: | 1.46 |
| Pivot price: | 1.34 |
| Support 1: | 1.19 |
| Support 2: | 1.03 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.080 |
| Book Value | 0.100 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.710 |
| Profit Margin (%) | -8.83 |
| Operating Margin (%) | -2.76 |
| Return on Assets (ttm) | 2.0 |
| Return on Equity (ttm) | -79.0 |
Company news
Mon, 27 Jul 2026
Akebia Therapeutics Inc (AKBA) Income Statement - TradingKey
Mon, 27 Jul 2026
Akebia Therapeutics Inc (AKBA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fri, 24 Jul 2026
AKBA Aug 2026 2.000 call (AKBA260821C00002000) stock price, news, quote and history - Yahoo Finance UK
Fri, 24 Jul 2026
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Given Average Rating of "Hold" by Brokerages - MarketBeat
Tue, 21 Jul 2026
Akebia Therapeutics (AKBA) Q2 2024 earnings summary - Quartr
Tue, 21 Jul 2026
Lobbying Update: $360,000 of AKEBIA THERAPEUTICS INC. lobbying was just disclosed - Quiver Quantitative
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
